Outcome | 2012-2014 | 2015-2017 | Unadjusted analysis | Adjusted analysis* | |||||
Out/Adm | % | Out/Adm | % | OR | 95% CI | adjOR | 95% CI | p | |
Mortality | 57/470 | 12.1 | 41/670 | 6.1 | 0.47 | 0.31 - 0.72 | 0.54 | 0.34 - 0.84 | 0.007 |
Length of stay > 7 days | 179/470 | 38.1 | 200/670 | 29.9 | 0.69 | 0.54 - 0.89 | 0.75 | 0.57 - 0.97 | 0.031 |
CRBSI | 26/470 | 5.5 | 20/670 | 3.0 | 0.53 | 0.290 - 0.95 | 0.61 | 0.33 - 1.12 | 0.111 |
Need for PMV | 303/470 | 64.5 | 389/670 | 58.1 | 0.76 | 0.598 - 0.97 | 0.85 | 0.65 - 1.12 | 0.238 |
PMV > 7 days | 133/303 | 43.9 | 111/389 | 28.5 | 0.51 | 0.372 - 0.70 | 0.54 | 0.39 - 0.74 | 0.000 |
VAP | 36/303 | 11.9 | 37/389 | 9.5 | 0.78 | 0.480 - 1.27 | 0.81 | 0.50 - 1.31 | 0.385 |